Evidence map›Paper›PMID 30179585›Full record

ArticleMedical decision making : an international journal of the Society for Medical Decision Making2018

Optimal Information Collection Policies in a Markov Decision Process Framework.

Lauren E Cipriano, Jeremy D Goldhaber-Fiebert, Shan Liu, Thomas A Weber

Abstract read
In one paragraph

Article in Medical decision making : an international journal of the Society for Medical Decision Making, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lauren E CiprianoIvey Business School, Western University, London, ON, Canada (LEC).ORCID 0000-0001-5568-4516
Jeremy D Goldhaber-FiebertIvey Business School, Western University, London, ON, Canada (LEC).
Shan LiuIvey Business School, Western University, London, ON, Canada (LEC).
Thomas A WeberIvey Business School, Western University, London, ON, Canada (LEC).ORCID 0000-0003-2857-4754

Funding

Cost-effective chronic disease prevention in developing countriesK01AG037593 · NIA · STANFORD UNIVERSITY · PI GOLDHABER-FIEBERT, JEREMY DAVID · 2011 to 2015
$637k
NIA NIH HHS K01 AG037593
6 · The paper itself

Abstract

backgroundThe cost-effectiveness and value of additional information about a health technology or program may change over time because of trends affecting patient cohorts and/or the intervention. Delaying information collection even for parameters that do not change over time may be optimal.

methodsWe present a stochastic dynamic programming approach to simultaneously identify the optimal intervention and information collection policies. We use our framework to evaluate birth cohort hepatitis C virus (HCV) screening. We focus on how the presence of a time-varying parameter (HCV prevalence) affects the optimal information collection policy for a parameter assumed constant across birth cohorts: liver fibrosis stage distribution for screen-detected diagnosis at age 50.

resultsWe prove that it may be optimal to delay information collection until a time when the information more immediately affects decision making. For the example of HCV screening, given initial beliefs, the optimal policy (at 2010) was to continue screening and collect information about the distribution of liver fibrosis at screen-detected diagnosis in 12 years, increasing the expected incremental net monetary benefit (INMB) by $169.5 million compared to current guidelines.

conclusionsThe option to delay information collection until the information is sufficiently likely to influence decisions can increase efficiency. A dynamic programming framework enables an assessment of the marginal value of information and determines the optimal policy, including when and how much information to collect.

Indexed as

Data AnalysisDecision Support TechniquesMarkov ChainsBiomedical TechnologyCost-Benefit AnalysisHepatitis CMass ScreeningQuality-Adjusted Life Yearsdynamic programminghepatitis CMarkov decision processesoptimal stoppingvalue-of-information analysis

Identifiers

PMID30179585
PMCPMC6690493

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.